CLINICAL USE
Diuretic, aldosterone antagonist
DOSE IN NORMAL RENAL FUNCTION
25–400 mg daily
PHARMACOKINETICS
DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsACE inhibitors or angiotensin-II antagonists: enhanced hypotensive effect; risk of severe hyperkalaemia
Antihypertensives: enhanced hypotensive effect; increased risk of first dose hypotensive effect with post-synaptic alpha-blockersCardiac glycosides: increased digoxin concentration; possibly increased digitoxin concentration
ADMINISTRATION
Reconstition
–
Route
Oral
Rate of Administration
–
Comments
–
OTHER INFORMATION
Renal patients are at an increased risk of hyperkalaemia and therefore spironolactone should be used with caution. It has active metabolites with long half-livesSmall studies have shown that doses of 25 mg of spironolactone 3 times a week can be safely used in haemodialysis patients although unknown whether that dose would be therapeutic – potassium levels should be monitored closely. Another small study used 25 mg daily but the potassium was monitored 3 times a week.